Another term used is distal symmetric peripheral neuropathy. Diabetic neuropathy of this sort is the most frequent. The feet and legs are initially affected, followed by the hands and arms. The following are some of the signs and symptoms of peripheral neuropathy that are often worse at night:
The autonomic nerve system regulates your heart, bladder, stomach, intestines, sex organs, and eyes. Diabetic nerve injury can occur in any of these regions, resulting in the following symptoms:
This type of neuropathy, also known as diabetic amyotrophy or diabetic polyradiculopathy, frequently affects the nerves in the thighs, hips, buttocks, or legs. However, it might impact the chest and abdomen as well. The symptoms normally appear on one side of the body, although they can move to the other.
Mononeuropathy is classified as either cranial or peripheral. Damage to a specific nerve is referred to as mononeuropathy. Mononeuropathy may also lead to:
The American Diabetes Association suggests that diabetic neuropathy screening begins shortly after a person is diagnosed with type 2 diabetes and five years after a person is diagnosed with type 1 diabetes. After that, screening is recommended annually.
Diabetic neuropathy is usually diagnosed by performing a physical exam, and carefully reviewing medical history and symptoms.
Your doctor will check your:
The specialists at Padda Institute, may perform or order specific tests to help diagnose diabetic neuropathy along with the physical exam, such as:
It is possible to prevent further nerve damage by controlling your blood sugar. Unfortunately, it won’t reverse the damage or relieve the pain caused by diabetic nerve damage. It may be necessary to receive a specific diabetic nerve pain treatment.
Oral drugs, which just mask the symptoms, are the most commonly used strategy.
Although a variety of pharmacological medications are available to treat the pain associated with diabetic neuropathy. The US Food and Drug Administration (US FDA) has only approved duloxetine and pregabalin for the treatment of diabetic neuropathic pain.
Pregabalin (Lyrica, Pfizer), the “gold standard” in treating peripheral neuropathy, helps 39 percent of patients attain a 50 percent reduction in their discomfort and pain, but it also causes problems in at least 38 percent of patients. These drugs have significant downsides and side effects. The FDA has not approved over-the-counter pain relievers to treat this type of discomfort.
EST uses electrical signals to regenerate nerves and increase blood flow by stimulating nerve function in the damaged areas. Electronic signal treatment relies on both varied amplitude (AM) and frequency (FM) of electronic signals using computer-controlled, exogenously delivered specific parameters of cell signals.
When applied to the human body, this digitally created electronic sinusoidal alternating current with associated harmonics creates scientifically documented and/or theorized physiological consequences. The electronic signal treatment medical device employs sophisticated communications technology to generate and transfer higher frequency signal energy via customized electrodes in a constantly altering sequential and random manner. This switching between sequential and random electronic signal supply removes neuron accommodation.
With the use of 0.25 percent Marcaine, a local anesthetic, and a vasodilator (opens blood vessels for a short time to enhance blood flow). When your nerves are stimulated, they receive more blood flow, which results in faster regeneration.
Combined therapy is believed to:
With a successful and acceptable pain management treatment plan, the patient will be able to regain more mobility.
Diabetes poses particular challenges to the feet due to the risk of nerve damage, sores, ulcers and circulation issues. Circulatory issues can deprive feet of nutrients that promote healing in addition to delayed wound care.